<?xml version="1.0" ?>
<document id="28610891">
  <sentence id="28610891.s0" text="Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (cysteine metabolic process), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).">
    <entity charOffset="152-178" id="28610891.s0.e0" ontology_id="GO_0006534" text="cysteine metabolic process" type="GO"/>
    <entity charOffset="274-298" id="28610891.s0.e1" ontology_id="HP_0001317" text="cerebellar abnormalities" type="HP"/>
    <pair e1="28610891.s0.e0" e2="28610891.s0.e1" id="28610891.s0.p0" relation="false"/>
  </sentence>
</document>
